Related by context. All words. (Click for frequent words.) 68 Corlux 65 CORT # 64 R#/MEM # 64 Phenoptin 63 vilazodone 63 HuLuc# 63 SILENOR 63 ATryn ® 63 SILENOR TM 63 alvimopan 63 PEG PAL 63 Genz # 62 CoFactor 62 ATryn R 62 Serdaxin 62 custirsen 62 AeroLEF TM 62 PS# [001] 62 AzaSite Plus 61 PRX # 61 mipomersen 61 phase IIa clinical 61 ALN TTR 61 torezolid phosphate 61 OncoVEX GM CSF 61 Ketotransdel 61 DR Cysteamine 61 Kuvan 61 TELINTRA 61 QNEXA 61 R#/MEM 61 Amigal 61 ALN PCS 61 AEGR 61 TREANDA 61 Traficet EN 61 MoxDuo IR 60 ISIS # 60 teduglutide 60 Ostarine 60 alemtuzumab MS 60 tezampanel 60 Ophena TM 60 Azedra 60 bicifadine 60 elotuzumab 60 valopicitabine 60 PRTX 60 HuMax EGFr 60 lomitapide 60 selective androgen receptor modulator 60 Oral NKTR 60 Phase 2a trial 60 Qnexa 60 PLK1 SNALP 60 diarrhea predominant irritable 60 PREOS R 60 refractory gout 60 Phase 2b clinical 60 vernakalant oral 60 Zerenex 60 NUVIGIL 60 Pimavanserin 59 ApoB SNALP 59 ADX# 59 registrational 59 diabetic neuropathic pain 59 BLA filing 59 Dapagliflozin 59 CCX# 59 Firazyr 59 Locteron 59 OLEPTRO TM 59 phase IIb 59 HspE7 59 TOCOSOL Paclitaxel 59 Clonicel 59 IND submission 59 Marqibo 59 MAA submission 59 CRx 59 Surfaxin LS 59 NGX# 59 otelixizumab 59 PREOS 59 Pivotal Phase 59 Locteron ® 59 JAK inhibitor 59 Spiegelmer ® 59 ProSavin 59 Sulonex TM 59 Amplimexon 59 Ophena 59 orBec 59 Q#IR 59 ALN VSP 59 Androxal 59 Zalbin 59 Phase IIB 59 pivotal Phase III 59 methylnaltrexone 59 Phase IIa trials 59 INKP 59 CIMZIA ™ 59 tanespimycin 59 L MTP PE 59 Zenvia ™ 59 ALN TTR# 59 eprotirome 59 Riquent 59 RDEA# 59 AEG# 59 Stedivaze 59 Plicera 59 INCB# [001] 59 Myocet 58 hoFH 58 confirmatory Phase III 58 NDA submission 58 virus HCV protease inhibitor 58 Capesaris 58 JOULFERON 58 investigational drug 58 phase IIb clinical 58 Phenserine 58 bifeprunox 58 PSN# [002] 58 ONCONASE 58 MEK inhibitor 58 HCV protease inhibitor 58 Phase III clinical trials 58 pseudobulbar affect PBA 58 Protexia R 58 Bicifadine 58 oral prodrug 58 lurasidone 58 Strativa 58 Civacir 58 PHX# 58 LymphoStat B 58 pramlintide 58 TriRima 58 Phase IIIb clinical 58 HGS ETR1 58 opioid induced bowel dysfunction 58 elagolix 58 Phase III clinical 58 alvespimycin 58 ELADUR 58 Vilazodone 58 Avanafil 58 visilizumab 58 forodesine 58 Rhucin ® 58 MAP# 58 Neo Kidney Augment 58 BENLYSTA ® 58 UPLYSO 58 Icatibant 58 BENLYSTA 58 FOLOTYN ® 58 retigabine 58 Rezular 58 AzaSite Xtra 58 Panzem R 58 Xcytrin R 58 dextromethorphan quinidine 58 Tyrima 58 clinical pharmacology studies 58 REMOXY R 58 Empatic 58 candidate Zenvia 58 BYDUREON 58 ALTU 58 Prodarsan ® 58 schizophrenia CIAS 58 oral deforolimus 58 MGCD# [001] 58 adipiplon 58 BCX# 58 NPSP# 58 Diabetic Macular Edema 58 metaglidasen 58 davunetide 58 Contrave 58 Fibrillex TM 58 XmAb# 58 oral ridaforolimus 58 PEG SN# 58 SNRI 58 Serdaxin ® 58 PDE4 inhibitor 58 TELCYTA 58 Menerba 58 PXD# 58 PrevOnco ™ 58 EGS# 58 MAGE A3 ASCI 57 Lu AA# 57 QRxPharma 57 Androxal TM 57 Aerosurf 57 Aurexis 57 reslizumab 57 cystinosis patients 57 Sulonex 57 PRE SURGE 57 Phase 2b trial 57 confirmatory Phase 3 57 INT# [002] 57 IL# PE#QQR 57 CINQUIL 57 eniluracil 57 aplindore 57 bardoxolone 57 pegylated interferons 57 Cetrorelix 57 Mipomersen 57 Trofex 57 CINTREDEKIN BESUDOTOX 57 PSMA ADC 57 RG# [001] 57 interferon gamma 1b 57 liprotamase 57 GSK# [002] 57 RHUCIN 57 tasimelteon 57 CD# CEA 57 SILENOR ™ 57 Asentar 57 Triolex 57 Omigard 57 prGCD 57 tamibarotene 57 OHR/AVR# 57 pharmacological chaperone 57 ruxolitinib 57 ramelteon 57 TMC# [002] 57 T Pred 57 Bezielle 57 Varespladib 57 refractory APL 57 regadenoson 57 iloperidone 57 DPP4 inhibitor 57 bremelanotide 57 omega interferon 57 ONTAK 57 fidaxomicin 57 Anturol 57 Phase IIb clinical 57 SNT MC# 57 LibiGel ® 57 registrational trial 57 LymphoStat B TM 57 AMR# 57 Chrysalin 57 GED aPC 57 IRX 2 57 avanafil 57 nonclinical studies 57 dimebon 57 LEVADEX 57 ARIKACE ™ 57 daclizumab 57 Allovectin 7 R 57 APD# 57 Azixa 57 ORENCIA ® 57 MEND CABG II 57 cannabinor 57 Guanilib 57 Phase IIb trials 57 Genasense ® oblimersen 57 Phase #b/#a trial 57 JANUVIA 57 Dextofisopam 57 ICA # 57 APF# 57 obatoclax 57 HCD# [002] 57 KALBITOR 57 Synavive 57 TRIOLEX 57 PRT# 57 6R BH4 57 Genasense R oblimersen 57 DXL# 57 HQK 57 Entereg R 57 tafamidis 57 Phase 1b trial 57 SparVax TM 57 EDEMA4 57 PEGylated interferon beta 1a 57 Acapodene 57 omacetaxine mepesuccinate 56 Panzem R NCD 56 maribavir 56 Cardio Vascu Grow 56 Phase Ib 56 ospemifene 56 bafetinib 56 darapladib 56 MyVax R 56 Anavex #-# 56 EDEMA3 56 DAVANAT 56 XP# XP# 56 BEMA TM Fentanyl 56 thymalfasin 56 lucinactant 56 HGS# 56 GATTEX 56 EndoTAG TM -1 56 telbivudine 56 IMA# 56 Pruvel 56 REMOXY ® 56 SomatoKine 56 ACTEMRA 56 intravenous methylnaltrexone 56 Egrifta 56 SUCCEED trial 56 OMAPRO 56 anti EGFR antibody 56 Relivar 56 Increlex ® 56 pitavastatin 56 Corcept 56 Nuvion 56 MDV# 56 Dyloject TM 56 ITAX 56 omecamtiv mecarbil 56 vidofludimus 56 Neurodex 56 Soliris TM eculizumab 56 ostarine 56 Elagolix 56 mGluR5 negative 56 RIGScan CR 56 vosaroxin 56 mapatumumab 56 lintuzumab 56 CTAP# Capsules 56 RSD# oral 56 Cinryze 56 initiate Phase 1b 56 Soriatane 56 oral calcitonin 56 ALGRX 56 lesinurad 56 nalbuphine ER 56 Zelrix 56 Alzhemed TM 56 OvaRex ® MAb 56 CORLUX CORT # 56 Plenaxis TM 56 novel VDA molecule 56 Revimmune 56 ELND# 56 Jevtana 56 Personalized Immunotherapy 56 Valortim 56 Androxal ® 56 oral methylnaltrexone 56 L BLP# 56 evaluating tivozanib 56 FavId 56 Oracea TM 56 INCB# [002] 56 pralatrexate 56 phase IIb trial 56 ularitide 56 Cethromycin 56 MEK inhibitor RDEA# 56 Phase 1b 56 sodium Injection 56 Proellex TM 56 celgosivir 56 rNAPc2 56 TKM ApoB 56 Quinamed 56 Phase 2a clinical 56 faropenem 56 dyskinesia PD LID 56 Allovectin 7 56 ridaforolimus 56 investigational monoclonal antibody 56 dirucotide 56 incyclinide 56 anidulafungin 56 NEUMUNE 56 Technosphere Insulin 56 TBC# 56 Phase Ib study 56 Dacogen injection 56 pradefovir 56 Ruconest 56 Phase IIa trial 56 Prodarsan R 56 HuMax CD4 56 Evamist TM 56 ACAPODENE 56 BLA submission 56 placebo controlled clinical 56 NDA resubmission 56 ORENCIA R 56 Fodosine 56 albinterferon alfa 2b 56 OXi# 56 insulin sensitizers 56 Restanza 56 oral taxane 56 MYDICAR 56 entinostat 56 MAXY VII 56 Protexia ® 56 KRYSTEXXA 56 atacicept 56 opioid bowel dysfunction 56 FIRAZYR 56 herpetic keratitis 56 postoperative ileus 56 KRN# 56 octreotide implant 56 IIa trial 56 fenofibric acid 56 lapatinib Tykerb 56 Octreolin 56 Zenvia Phase III 56 ongoing Phase IIIb 56 IDX# 56 AZILECT R 56 Cimzia TM 56 Intuniv 56 Viprinex TM 56 HuMax CD# 56 teplizumab 56 Stimuvax 55 Cellegesic 55 HGS ETR2 55 RNAi therapeutic targeting PCSK9 55 tezampanel NGX# 55 sargramostim 55 ONCONASE R 55 PhosLo 55 THALOMID 55 Phase III Clinical Trials 55 liposomal formulation 55 talactoferrin 55 Chemophase 55 ZEGERID Capsules 55 Azedra TM 55 HZT 55 zileuton CR 55 CR# vcMMAE 55 aripiprazole Abilify 55 favorable pharmacokinetic profile 55 Cleviprex TM clevidipine 55 desvenlafaxine 55 Gemzar ® 55 sodium thiosulfate STS 55 Solazed TM 55 dose cohort 55 GALNS 55 HEPLISAV 55 Epanova 55 azficel T 55 oxymorphone ER 55 glucokinase activator 55 zileuton 55 Prestara TM 55 FOLOTYN 55 synthetic retinoid 55 MERLIN TIMI 55 PROVENGE sipuleucel T 55 Zingo TM 55 Phase 1a clinical 55 IPLEX 55 Horizant 55 Homspera 55 Viramidine 55 lumiliximab 55 preclinical toxicology 55 sorafenib tablets 55 PD LID 55 Intermezzo R 55 HGS ETR1 mapatumumab 55 pharmacodynamic effects 55 Cannabinor 55 Sanctura XR 55 Phase IIa clinical 55 Nasulin 55 sNDA submission 55 interferon beta 1b 55 velafermin 55 Neo Kidney Augment ™ 55 CIMZIA TM 55 Gabapentin GR 55 pharmacokinetic studies 55 RAPAFLO 55 axitinib 55 Entereg TM 55 doxepin HCl 55 placebo controlled Phase 55 ganetespib 55 ambrisentan 55 VitiGam 55 ELACYT 55 Meets Primary Endpoint 55 oral FTY# 55 Prostate AdenoCarcinoma Treatment 55 AERx iDMS 55 dacetuzumab 55 MEK inhibitors 55 Hyphanox 55 FM VP4 55 Exherin TM 55 ofatumumab 55 dextofisopam 55 Azilect ® 55 Keppra XR 55 CYCLOSET 55 GAMMAGARD 55 Phase IIb 55 Phase IIb trial 55 Insegia 55 Aplidin R 55 Iluvien ® 55 Focalin XR 55 Exelbine 55 midstage clinical 55 mixed dyslipidemia 55 opioid induced constipation 55 Diamyd ® 55 Huntexil 55 BEMA Buprenorphine 55 PROMACTA 55 Onrigin TM 55 mifamurtide 55 Rhucin 55 ASONEP 55 EFAPROXYN 55 ZOLINZA 55 SPRYCEL ® 55 TG# [003] 55 phase Ib 55 maximally tolerated dose 55 linaclotide 55 SinuNase 55 FACTIVE tablets 55 RGB # 55 Rebif ® 55 ZYFLO 55 postoperative ileus POI 55 selective modulator 55 pegloticase 55 indiplon 55 Phase #b/#a 55 pegylated interferon alpha 55 ALVESCO HFA 55 Anthim 55 RSD# 55 MOZOBIL 55 TLK# 55 ketolide antibiotic 55 Tovaxin 55 CEQ# 55 Levetiracetam 55 Evoltra 55 Cethrin 55 formerly LymphoStat B 55 Virulizin ® 55 hepatic encephalopathy 55 BEMA Granisetron 55 Numax 55 GTC recombinant human 55 Virulizin R 55 OMNARIS HFA 55 tiapamil 55 febuxostat 55 LEVADEX TM 55 ABILIFY R 55 SNALP technology 55 Phase 2a clinical trials 55 Archexin 55 MAXY G# 55 ADVEXIN 55 Xenazine ® 55 lanthanum carbonate 55 Zoraxel 55 FUSILEV 55 ponatinib 55 pexelizumab 55 FUSILEV ® 55 clinical trials 55 acyclovir Lauriad R 55 YONDELIS 55 DPX Survivac 55 Arcalyst 55 omacetaxine 55 APOPTONE 55 AFRESA 55 goserelin 55 KNS # 55 Ventavis 55 CCR9 antagonist 55 heterozygous FH 55 tesetaxel 55 INS# [001] 55 trodusquemine 55 Prestara 55 PDX pralatrexate 55 mGluR5 NAM 55 OMNARIS Nasal Spray 55 REMINYL ® 55 ONGLYZA 55 NEBIDO 55 oral rivaroxaban 55 oritavancin 55 glufosfamide 55 VIAject R 55 DexaSite 55 ezogabine 55 INC# 55 ABILIFY ® 55 severe hypercholesterolemia 55 Phase 2a 55 Phase 2b study 55 DDP# 55 Staccato loxapine 55 IMiDs 55 migraine prophylaxis 55 HepeX B 55 Tasimelteon 55 TRANSDUR Sufentanil 55 StaphVAX R 55 SAR# [002] 55 squalamine 55 ACUROX ® 55 MACUGEN 55 Zelapar 55 nab paclitaxel 55 balsalazide tablet 55 DAVANAT R 55 primary hypercholesterolemia 55 Randomized Phase 55 Ketotransdel ® 55 MethyPatch 55 Golimumab 54 PRISTIQ 54 ACV1 54 Leukine ® 54 HuMax CD#b 54 MT# MEDI 54 Pivotal Phase III 54 teriflunomide 54 telaprevir VX 54 CYT# potent vascular disrupting 54 AVONEX ® 54 AQ4N 54 ecallantide 54 desvenlafaxine succinate 54 carfilzomib 54 Evoltra ® 54 PEG Interferon lambda 54 panitumumab 54 subcutaneous formulation 54 Duromist ™ 54 thorough QT 54 REPLAGAL 54 Cinryze ™ 54 drug pipeline TAFA# 54 Aflibercept 54 huC# DM4 54 Nebido 54 systemic immunosuppressive drugs 54 Initiated Phase 54 NeuroSTAT ® 54 Ramoplanin 54 PEGINTRON TM 54 NP2 Enkephalin 54 Frova ® 54 lixivaptan 54 relapsed multiple myeloma 54 Xanafide 54 Cimzia ® certolizumab pegol 54 successfully commercialize Iluvien 54 Vandetanib 54 PANVAC VF 54 lintuzumab SGN 54 Targretin 54 systemically administered 54 AeroLEF 54 pharmacokinetic PK 54 EVIZON TM squalamine lactate 54 HepeX B TM 54 deforolimus 54 epigenetic therapies 54 Amoxicillin PULSYS 54 Biologics License Application BLA 54 Troxatyl 54 PEG INTRON 54 CIPN 54 Onalta ™ 54 temsirolimus 54 viral kinetic 54 Ceflatonin 54 ocrelizumab 54 investigational humanized monoclonal antibody 54 Welchol 54 IMC #B 54 milnacipran 54 eltrombopag 54 ADVANCE PD 54 Altropane 54 ozarelix 54 Viprinex 54 MYDICAR ® 54 indiplon capsules 54 Ixempra 54 VIVITROL ® 54 tocilizumab 54 proprietary transdermal patch 54 SAR# [004] 54 tecarfarin 54 safinamide 54 eszopiclone 54 paliperidone palmitate 54 alogliptin 54 tivozanib 54 Abilify aripiprazole 54 ACTEMRA TM 54 Ketotransdel TM 54 catheter occlusion 54 ALN RSV# 54 AZILECT ® 54 HCV protease inhibitors 54 orBec R 54 Acetavance 54 JZP 54 Marketing Authorization Application 54 Bepreve 54 QNEXA ® 54 confirmatory clinical 54 Combunox 54 leading oral taxane 54 ranolazine 54 carcinogenicity study 54 RAPTIVA 54 TH# [003] 54 Probuphine 54 Urocortin 2 54 sumatriptan DosePro 54 multicenter Phase 54 metformin sulfonylurea 54 hyperuricemia 54 Relovair 54 pertuzumab 54 Apoptone 54 Zemiva TM 54 URG# 54 pirfenidone 54 Contrave# 54 ENRICH trial 54 LE SN# 54 AP# [003] 54 Zorbtive TM 54 pimavanserin 54 ILUVIEN ® 54 Ticagrelor 54 Ranexa R 54 SURFAXIN 54 ulimorelin 54 Emselex 54 cintredekin besudotox 54 mertansine 54 INVEGA SUSTENNA 54 sulodexide 54 Silenor ® 54 Cipralex ® 54 Safinamide 54 tolevamer 54 Captisol enabled 54 EOquin 54 Diabetic Macular Edema DME 54 ZALBIN 54 RLY# 54 VIAtab TM 54 CBLC# 54 candidate XP# 54 ® natalizumab 54 Navelbine ® 54 Effexor venlafaxine 54 Itopride 54 DPP4 54 methylnaltrexone bromide 54 Neo Urinary Conduit 54 Qutenza 54 investigational oral therapy 54 TYZEKA 54 CCX# B 54 investigational antiplatelet agent 54 CAPHOSOL 54 Zebinix R 54 Emezine 54 AZD# 54 Poly ICR 54 Aphthasol R 54 LEVADEX ™ 54 Exalgo TM 54 Biologics License Application 54 orally bioavailable 54 ganaxolone 54 palonosetron 54 FluCide 54 Heplisav 54 APPRAISE 54 Orazol 54 SUPPRELIN R LA 54 Abiraterone acetate 54 Anturol ® 54 urocortin 2 54 forodesine hydrochloride 54 preclinical pharmacokinetic 54 Vivitrex 54 IMGN# 54 compound INCB# 54 picoplatin 54 Actimmune ® 54 BiovaxID TM 54 nitazoxanide 54 perifosine 54 Phase Ib clinical trials 54 Veronate 54 metastatic sarcomas 54 SinuNase TM 54 LEP ETU 54 Valdoxan 54 bardoxolone methyl 54 Onalta 54 NXL# 54 Xyfid TM 54 TRANSDUR ™ 54 post herpetic neuralgia PHN 54 investigational compounds 54 erlotinib Tarceva R 54 Solzira 54 Sular formulation 54 lasofoxifene 54 Zenvia 54 ADAGIO study 54 sunitinib malate 54 carbidopa levodopa 54 pivotal Phase 54 TORISEL 54 non alcoholic steatohepatitis 54 Rasagiline 54 Celacade TM technology 53 Inhalation Solution 53 bortezomib Velcade 53 exenatide once 53 chemotherapy induced neutropenia 53 Fentanyl Taifun 53 Exelixis compounds 53 rilonacept 53 Amrubicin 53 XL# XL# XL# 53 davalintide 53 rFIXFc 53 ONGLYZA ™ 53 OMS#HP 53 IND enabling 53 TRANSDUR ® 53 SinuNase ™ 53 EndoTAG TM 53 perampanel 53 MBP# [001] 53 Proquin XR 53 CDP# 53 ENTEREG ® 53 triglyceride lowering 53 GSK# [001] 53 THR beta agonist 53 GATTEX ® 53 Alocrest 53 ZFP Therapeutic 53 dacetuzumab SGN 53 antibody MAb 53 Phase 1b clinical 53 NV1FGF 53 ONSOLIS 53 Cinryze TM 53 Naproxcinod 53 treat opioid induced 53 ataluren 53 aripiprazole 53 ARCOXIA 53 SEROQUEL 53 Rhucin ® recombinant 53 relapsed refractory multiple myeloma 53 Frova R 53 pramlintide metreleptin 53 ONTARGET 53 Posiphen 53 Phase 2b 53 GRALISE 53 Aryplase 53 Silenor 53 ACUROX 53 Phase Ib clinical 53 XL# SAR# 53 XL# anticancer compounds 53 luliconazole 53 Nexavar ® 53 bazedoxifene 53 GSK # 53 non metastatic osteosarcoma 53 TRO# 53 Iloperidone 53 phase IIa 53 drug eluting coronary stent 53 Oxytrex 53 TACI Ig 53 linagliptin 53 Sym# 53 Octreotide 53 Satraplatin 53 Solazed 53 prucalopride 53 DCCR 53 targeted radiotherapeutic 53 exenatide LAR 53 Trexima 53 active comparator 53 BeneFIX 53 Lialda 53 CaPre TM 53 refractory Hodgkin lymphoma 53 Microplasmin 53 erlotinib Tarceva ® 53 granulated mesalamine 53 PRECISE trial 53 MultiStem 53 cancer immunotherapies 53 subcutaneous RELISTOR 53 Onconase 53 Phase 2b Clinical Trial 53 tesofensine 53 AMEVIVE 53 Ereska 53 Rhucin R 53 investigational pan BCR 53 IMP# 53 EOquin TM 53 Tavocept 53 CTA# Injection 53 Desmoteplase 53 Ceflatonin ® 53 anticancer agent 53 oral gallium 53 metreleptin 53 pomalidomide 53 homozygous familial hypercholesterolemia 53 AZD# TC 53 levocetirizine 53 telavancin 53 Mepact 53 overactive bladder AA# 53 Phase III trials 53 ALKS 53 Milnacipran 53 ofatumumab HuMax CD# 53 Tezampanel 53 beta 1a 53 TOCOSOL Camptothecin 53 paliperidone ER 53 hypoparathyroidism 53 Besivance 53 Linjeta TM 53 AAG geldanamycin analog 53 IV Busulfex 53 EvaMist TM 53 SGS# 53 RELOVAIR ™ 53 ATL# [001] 53 TREDAPTIVE 53 investigational atypical antipsychotic 53 Symadex 53 Fortical R 53 HeFH 53 GATTEX ™ 53 danoprevir 53 CANCIDAS 53 Symbyax 53 pharmacokinetic PK study